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TT performance between conditions (2643.1 ± 324. 1 vs. 
2649.9 ± 319.8 s, P > 0.05).
Conclusion Acute BRJ supplementation significantly 
enhanced 1500  m, but not 10,000  m TT performance. 
These findings suggest that BRJ might be ergogenic during 
shorter distance TTs which allow for a high work rate, but 
not during longer distance TTs, completed at a lower work 
rate.
Keywords Nitric oxide · Beetroot juice · Dietary 
supplementation · Exercise performance
Abbreviations
ANOVA  Analysis of variance
ATP  Adenosine triphosphate
BP  Blood pressure
BRJ  Nitrate-rich beetroot juice
Ca2+  Calcium
DTPA  Diethylenetriaminepentaacetic acid
HR  Heart rate
MAP  Mean arterial pressure
NEM  N-Ethylmaleimide
NO  Nitric oxide
NO2−  Nitrite
NO3−  Nitrate
NOS  Nitric oxide synthase
O2  Oxygen
PCr  Phosphocreatine
PO2  Partial pressure of oxygen
PLA  Nitrate-deplete beetroot juice
RER  Respiratory exchange ratio
RPE  Ratings of perceived exertion
SWC  Smallest worthwhile change
TT  Time-trial
TTE  Time to exhaustion
Abstract 
Purpose This study evaluated the effects of dietary nitrate 
 (NO3−) supplementation on physiological functioning and 
exercise performance in trained runners/triathletes conduct-
ing short and longer-distance treadmill running time-trials 
(TT).
Method Eight trained male runners or triathletes com-
pleted four exercise performance tests comprising a 10 min 
warm up followed by either a 1500 or 10,000 m treadmill 
TT. Exercise performance tests were preceded 3  h before 
the exercise by supplementation with either 140  ml con-
centrated nitrate-rich (~12.5 mmol nitrate) (BRJ) or nitrate-
deplete (~0.01 mmol nitrate) (PLA) beetroot juice.
Results BRJ supplementation significantly elevated 
plasma  [NO2−] (P < 0.05). Resting blood pressure and exer-
cise V̇O
2
 were not significantly different between BRJ and 
PLA (P > 0.05). However, post-exercise blood [lactate] 
was significantly greater in BRJ following the 1500 m TT 
(6.6 ± 1.2 vs. 6.1 ± 1.5 mM; P < 0.05), but not significantly 
different between conditions in the 10,000 m TT (P > 0.05). 
Performance in the 1500 m TT was significantly faster in 
BRJ vs. PLA (319.6 ± 36.2 vs. 325.7 ± 38.8  s; P < 0.05). 
Conversely, there was no significant difference in 10,000 m 
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V̇CO
2
  Carbon dioxide production
V̇O
2
  Oxygen uptake
V̇O
2max
  Maximal oxygen uptake
Introduction
Nitric oxide (NO) is a reactive gaseous signalling molecule 
that regulates a broad range of physiological processes, 
including muscle contraction (Reid 1998), mitochondrial 
respiration (Clerc et  al. 2007), vasodilation (Kelm and 
Schrader 1990), and immune function (Bogdan 2001). 
NO can be generated by the NO synthase (NOS) family of 
enzymes from the precursors l-arginine and oxygen  (O2), 
in a complex reaction that requires the presence of multiple 
cofactors (Moncada and Higgs 1993). A complementary 
pathway for NO production has also been elucidated, and 
entails the reduction of nitrate  (NO3−) into nitrite  (NO2−) 
by oral bacteria (Duncan et  al. 1995), and subsequent 
reduction of  NO2− into NO throughout the body via mul-
tifarious enzymatic and non-enzymatic catalysts (Lundberg 
and Govoni 2004).
A strong body of evidence indicates that  NO3− sup-
plementation can improve time to exhaustion (TTE) and/
or time-trial (TT) performance during short duration 
(<30 min) exercise tests, which mandate a high relative (to 
the peak) work rate (Bailey et  al. 2009, 2010; Vanhatalo 
et al. 2010; Lansley et al. 2011; Cermak et al. 2012a; Por-
celli et  al. 2014; McMahon et  al. 2016), particularly in 
untrained and moderately-trained individuals (V̇O
2max
 < 
~60 ml kg−1 min−1). Notably, Lansley et al. (2011) reported 
a significant and comparable improvement in 4  km (TT 
duration: ~6  min; performance improvement: 2.8%) and 
16.1  km (TT duration: ~ 28  min; performance improve-
ment: 2.7%) cycle ergometry TT performance in moder-
ately trained males (V̇O
2max
 ~56 ml kg−1 min−1) consequent 
to  NO3− ingestion. Conversely,  NO3− supplementation has 
been reported to have a minimal effect on performance dur-
ing longer duration (>30  min) exercise tests, which man-
date a lower work rate (Bescós et al. 2012; Wilkerson et al. 
2012; Cermak et al. 2012b; Lane et al. 2014; Glaister et al. 
2015).
The precise reasons for this disparity are unclear, but 
might be related to differences in muscle recruitment pat-
terns between short and longer duration exercise tests. 
Recent data from murine models suggest that  NO3− sup-
plementation elevates blood flow and oxygenation (Fergu-
son et al. 2013, 2015), and increases calcium  (Ca2+) han-
dling protein expression and force production (Hernandez 
et  al. 2012) in type II muscle only (for review, see Jones 
et al. 2016). Therefore, the beneficial effects of  NO3− sup-
plementation might be restricted to, or most pronounced 
during, exercise where type II fibers are predominantly 
recruited (Breese et  al. 2013; Bailey et  al. 2015; Coggan 
et al. 2015), such as during short duration exercise where a 
higher relative work rate can be adopted (Essén 1978; Sale 
1987). Additionally, hypoxia and acidosis—cellular con-
ditions particularly prevalent at higher work rates (Rich-
ardson et  al. 1995; Robergs et  al. 2004)—are known to 
enhance the reduction of  NO2− into NO (Modin et al. 2001; 
Cosby et  al. 2003; Castello et  al. 2006). Consequently, 
 NO3− supplementation may be more effective at elevating 
 NO2− derived NO, and thus enhancing NO signalling, dur-
ing short duration exercise tests where a high work rate is 
adopted, compared with longer duration exercise tests con-
ducted at a lower work rate.
Previous investigations utilising longer duration 
(>30  min) exercise tests have employed trained subjects 
(Males: V̇O
2max
 >60 ml  kg−1  min−1, Females: V̇O
2max
 
>50 ml kg−1 min−1), who manifest a diminished response 
to  NO3− supplementation (Porcelli et  al. 2014). This may 
be explained by the elevated baseline plasma  [NO3−] and 
 [NO2−] in this cohort (Vassalle et al. 2003), although mul-
tiple other factors may also be important (Jones 2014). It is 
therefore unclear whether the reduced effects of  NO3− sup-
plementation reported during longer vs. shorter duration 
exercise tests are related to the exercise duration (and req-
uisite work rate) or the high training status of subjects in 
these investigations (Bescós et  al. 2012; Wilkerson et  al. 
2012; Cermak et al. 2012b; Lane et al. 2014; Glaister et al. 
2015). Direct comparison between the effects of  NO3− sup-
plementation on short and longer duration (< or >30 min) 
exercise performance where other methodological variables 
are fixed is necessary, yet presently scarce.
Therefore, the purpose of this investigation was to evalu-
ate the effects of  NO3− supplementation on short duration 
high work rate (1500  m; ~5  min) versus longer duration 
lower work rate (10,000 m; ~45 min) treadmill running TT 
performance in a group of trained men following an identi-
cal  NO3− supplementation regimen. We hypothesized that 
 NO3− supplementation would enhance short, but not longer 
duration exercise performance.
Methods
Subjects
Eight trained male runners or triathletes (age: 28.3 ± 5.8 
years, body mass: 74.7 ± 10.1  kg, height 179.1 ± 2.4  cm, 
V̇O
2max
: 62.3 ± 8.1 ml kg−1 min−1) volunteered to take part 
in this study. The subjects all had experience of compet-
ing in running events. The procedures and any associated 
risks and benefits of the study were explained to the sub-
jects, after which they gave fully informed written consent. 
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The study received institutional ethical clearance, and was 
conducted in accordance with the Declaration of Helsinki.
Experimental design
Each subject visited the laboratory on six separate occa-
sions. On the first visit, subjects completed an incremental 
exercise test to exhaustion to determine their maximal rate 
of oxygen uptake (V̇O
2max
) and elucidate suitable sub-maxi-
mal warm up exercise intensities for the experimental trials. 
Following a rest period of approximately 20 min, subjects 
then completed familiarization of the 1500 m TT. On the 
second visit to the laboratory, subjects completed familiari-
zation of the 10,000 m TT. The third to sixth visits included 
each of the following performance trials: (1) 1500  m TT 
preceded by nitrate-rich beetroot juice (BRJ) supplementa-
tion; (2) 1500  m TT preceded by nitrate-deplete beetroot 
juice (PLA) supplementation; (3) 10,000  m TT preceded 
by BRJ supplementation; (4) 10,000  m TT preceded by 
PLA supplementation. Performance trials were conducted 
in a randomized order, with 140  ml concentrated BRJ 
(~12.5  mmol nitrate) or PLA (~0.01  mmol nitrate) (Beet 
It, James White Ltd., Ipswich, UK) administered double 
blind, 3 h before the start of exercise. The exact  NO3− con-
tent of the beetroot juice was determined via ozone-based 
chemiluminescence, as previously described (Shannon 
et al. 2016b). Subjects were asked to complete a food and 
exercise diary for 24 h prior to the first experimental trial, 
and used this to replicate their diet and activity as closely 
as possible for subsequent visits. During this time period, 
subjects were asked not to perform strenuous exercise, or 
consume caffeine and alcohol. Subjects were also asked not 
to consume anything except for water in the 3 h before test-
ing. Antibacterial mouthwash and chewing gum were also 
avoided throughout the testing period, as these are known 
to destroy the oral bacteria responsible for nitrate reduc-
tion into nitrite (Govoni et al. 2008). Each testing sessions 
was conducted at the same time of the day to minimise the 
influence of circadian variance.
Maximal exercise testing
Subjects completed a two-part incremental running test 
on a motorized treadmill (Woodway, Cranlea, Birming-
ham, UK) (Jones 2007). The first part of the test comprised 
five to eight, 3-min sub-maximal stages, separated with 
1  min recovery periods. Running speed was increased by 
1  km  h−1 each stage. A finger-tip blood sample was also 
obtained between stages to determine blood [lactate] (YSI 
2300 STAT plus, Yellow Springs, Ohio, USA). At the end 
of each stage, heart rate (HR) was monitored via a chest 
worn strap (Polar Electro, Oy, Finland), and ratings of per-
ceived exertion (RPE) was assessed using a 15-point (6–20) 
scale. A 1% treadmill gradient was applied to replicate the 
energetic cost of running outdoors (Jones and Doust 1996). 
Exercise was stopped when blood [lactate] exceeded 4 mM. 
Subjects then rested for approximately 5 min, after which 
the second phase of the test commenced. A fixed running 
speed was applied, equal to the final speed achieved during 
the first part of the test, minus 2 km h−1. Treadmill gradient 
was increased by 1% every minute, until volitional exhaus-
tion. An online gas analysis system (MedGraphics Ultima 
CPX, MGC Diagnostics, MN, USA), calibrated before each 
trial according to the manufacturer’s instructions, was used 
to monitor expired gas throughout exercise. Expired gas 
data was used to define V̇O
2max
 (greatest 30 s mean value) 
and the relevant sub-maximal running speeds for the exper-
imental trials. All subjects were deemed to have attained 
V̇O
2max
, as they achieved ≥2 of the following criteria: a pla-
teau in V̇O
2
 in the final exercise stage (Taylor et al. 1955), 
RER ≥1.15 (Issekutz et al. 1962), HR within 10 b min−1 of 
age-predicted maximum (220—age), RPE ≥19, blood [lac-
tate] ≥8 mM (Midgley et al. 2007).
Performance trials
Approximately 1  week after the 10,000  m familiarization 
trial, subjects completed the first of four performance tri-
als. All performance trials were conducted over a 3–5-week 
period, with a minimum of 5 days and maximum of 10 days 
between visits. These consisted of 10  min of continuous 
treadmill running as a warm up period, split as 5 min bouts 
at 45 and 65% V̇O
2max
, respectively. After a 5-min pas-
sive rest period, subjects then completed either a 1500 or a 
10,000 m TT. Each TT commenced with a 30 s rolling start 
at a running speed approximating 80% V̇O
2max
, after which 
subjects could freely adjust their speed. Running speed and 
time were not visible to subjects during the TT. Subjects 
were verbally informed of the distance they had covered at 
200 m (1500 m TT) or 500 m (10,000 m TT) intervals. The 
treadmill gradient was set to 1% throughout the exercise 
(Jones and Doust 1996).
Measurements
Prior to the start of each performance trial, subjects were 
required to sit for a 10-min period, after which blood 
pressure (BP) of the brachial artery was measured using 
an automated sphygmomanometer (Omron Healthcare 
Ltd., Kyoto, Japan). Four measures were obtained, and 
the mean value of the final three measurements was used 
for data analysis. An 8 ml venous blood sample was then 
collected via venepuncture from a vein in the arm into 
lithium heparin containing tubes. Blood was immediately 
centrifuged at 5000 rpm for 3 min. Plasma was extracted 
into opaque cryotubes (Argos Technologies, IL, USA), 
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which were pre-treated with 6.5  mM N-ethylmaleim-
ide (NEM) and 0.1  mM Diethylenetriaminepentaacetic 
acid (DTPA) to prevent the interchange between NO 
metabolites (Nagababu and Rifkind 2010). Cryotubes 
were immediately placed in a freezer at −80 °C, for 
later analysis of plasma  [NO2−] via ozone-based chemi-
luminescence, as previously described (Shannon et  al. 
2016b). A blood sample was also collected from the fin-
gertip, to determine blood [lactate] (YSI 2900, Yellow 
Springs, OH, USA). A further fingertip blood sample was 
obtained immediately after exercise, and an additional 
venous blood sample was collected within 5  min of TT 
completion to monitor the change in plasma  [NO2−]. HR 
and RPE were monitored immediately following comple-
tion of the TT, as previously described. Expired gas was 
monitored continuously throughout TT exercise, as previ-
ously described.
Data analysis
Data analysis was conducted using SPSS version 22. 
An α level of P < 0.05 was accepted for significance. 
Between-supplement differences in plasma  [NO2−], the 
transient change in pulmonary gas data, blood [lactate], 
and TT splits and running speed were compared in the 
1500 and 10,000 m exercise testing sessions using a two-
way (time  ×  condition) repeated measures ANOVA. In 
the 1500  m condition, pulmonary gas data, TT splits, 
and running speed were averaged over 200  m intervals 
to 1400  m, and then during the final 100  m. Alterna-
tively, these data were averaged over 1000  m intervals 
for the 10,000  m TT. Post-hoc analysis was conducted 
using t-tests with a Bonferroni correction. Between-sup-
plement differences in BP, post-exercise HR and RPE, 
mean (average during the entire TT) V̇O
2
, V̇CO
2
, RER, 
and TT performance were compared in the 1500 and 
10,000 m exercise testing sessions using a paired t-test. A 
statistical spreadsheet was also applied to derive qualita-
tive probabilistic inferences for performance data (Hop-
kins 2007). Comparisons were made against a smallest 
worthwhile change (SWC) of 0.5% derived from previ-
ously published data (Russell et al. 2004; Shannon et al. 
2016a). Verbal descriptors were used to express the 
chance that the true value of the effect was beneficial, 
trivial, or harmful, according to the following scale: < 
0.5%, ‘almost certainly not’; 0.5–5%, ‘very unlikely not’; 
5–25%, ‘unlikely’; 25–75%, ‘possibly’; 75–95%, ‘likely’; 
‘95–99.5%’, ‘very likely’; >99.5%, ‘almost certainly’. 
The effect was deemed unclear when an odds ratio of 
benefit to harm of <66 was identified, corresponding to 
a 25% chance of benefit and 0.5% risk of harm. Data are 
presented as mean ± SD, unless otherwise stated.
Results
Plasma  [NO2−] and blood pressure
Plasma  [NO2−] data for the 1500 and 10,000 m exercise 
test protocols is presented in Fig. 1. Pre-exercise plasma 
 [NO2−] was significantly elevated in BRJ compared with 
PLA prior to both the 1500 and 10,000 m TTs (P < 0.05). 
Pre-exercise plasma  [NO2−] tended to be greater in the 
1500  m compared to 10,000  m BRJ condition, and was 
significantly greater prior to the 1500  m compared with 
the 10,000 m exercise testing session in PLA (P < 0.05). 
Plasma  [NO2−] remained significantly elevated in both 
BRJ conditions post-exercise compared with PLA 
(P < 0.05). In the 1500  m exercise test protocol, post-
exercise plasma  [NO2−] was significantly decreased in 
BRJ relative to pre-exercise levels (P < 0.05). In con-
trast, plasma  [NO2−] was not significantly different to 
pre-exercise levels in PLA (P > 0.05). In the 10,000  m 
exercise test protocol, post-exercise plasma  [NO2−] was 
not significantly different to pre-exercise levels in either 
BRJ (P > 0.05) or PLA (P > 0.05). Post-exercise plasma 
 [NO2−] was not significantly different between the two 
BRJ conditions, or between the two PLA conditions 
(P > 0.05).
There was no difference in mean arterial blood pres-
sure (MAP) in BRJ compared with PLA prior to the 
1500 m (BRJ 92 ± 5 vs. PLA 92 ± 5 mmHg; P > 0.05) nor 
10,000  m (BRJ 94 ± 6 vs. PLA 94 ± 6  mmHg; P > 0.05) 
exercise test protocols.
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Fig. 1  Group mean ± SEM pre and post-exercise plasma  [NO2−] in 
BRJ (closed circles/triangles) and PLA (open circles/triangles). BRJ 
significantly elevated plasma  [NO2−] above PLA in both 1500 and 
10,000 m conditions (*) (P < 0.05). Pre-exercise plasma  [NO2−] was 
significantly greater in 1500 m PLA compared to 10,000 m PLA (+) 
(P < 0.05). Plasma  [NO2−] significantly decreased in 1500 m BRJ (#) 
(P < 0.05)
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Heart rate and ratings of perceived exertion
HR and RPE assessed immediately following the TTs did 
not differ significantly between BRJ and PLA (P > 0.05; 
Table 1).
Pulmonary gas exchange
Mean pulmonary V̇O
2
, V̇CO
2
, and RER data throughout 
the 1500 and 10,000  m TTs did not differ significantly 
between BRJ and PLA (P > 0.05; Table  1). The transient 
change in these data at 200  m (1500  m TT) and 1000  m 
(10,000 m TT) intervals throughout the TT is presented in 
Fig. 2. These variables did not differ significantly between 
BRJ and PLA at any time point (P > 0.05).
Blood [lactate]
Pre-exercise blood [lactate] was not significantly differ-
ent between BRJ and PLA in either exercise test protocol 
(P > 0.05). In the 1500 m exercise test protocol, post-exer-
cise blood [lactate] was significantly greater in BRJ com-
pared with PLA (6.6 ± 1.2 vs. 6.1 ± 1.5  mM; P < 0.05), 
however, not different between BRJ and PLA in the 
10,000 m exercise test protocol (4.5 ± 1.5 vs. 4.2 ± 0.8 mM; 
P > 0.05).
Time trial performance
Individual performance times and running speed for the 
1500 and 10,000 m TT are presented in Fig. 3.
1500 m TT
Completion time was significantly faster in BRJ 
(319.6 ± 36.2  s) compared with PLA (325.7 ± 38.8  s; 
P < 0.05) for the 1500  m TT. Magnitude based infer-
ences indicated a ‘very likely beneficial’ effect of BRJ on 
group mean 1500 m TT performance. Six of eight subjects 
exceeded the SWC for an improvement in 1500 m TT per-
formance in BRJ vs. PLA (Fig. 3a). There was no signifi-
cant difference in running speed at any of the 200 m (up to 
1400 m) and final 100 m (1400–1500 m) splits (P > 0.05, 
Fig. 3b).
10,000 m TT
There was no significant difference in 10,000 m TT com-
pletion time between BRJ (2643.1 ± 324.1  s) compared to 
PLA (2649.9 ± 319.8  s, P > 0.05). Magnitude-based infer-
ences indicated an ‘unclear’ effect of BRJ on group mean 
10,000 m TT performance. However, four of eight subjects 
exceeded the SWC for an improvement in 10,000  m TT 
performance in BRJ vs. PLA (Fig. 3c). There was no sig-
nificant difference in running speed at any of the 1000 m 
splits (P > 0.05, Fig.  3d). However, when the TT was 
divided into two, 5000  m segments for analysis, subjects 
had a significantly faster running speed (BRJ 14.0 ± 1.6 vs. 
PLA 13.7 ± 1.5  km  h−1, P < 0.05) and quicker time (BRJ 
1287.5 ± 153 vs. PLA 1317.6 ± 149.9 s, P < 0.05) in the first 
5000 m with BRJ compared to PLA. There was no differ-
ence in running speed (BRJ 13.3 ± 1.8 vs. PLA 13.5 ± 1.8 
km·h−1, P > 0.05) nor time (BRJ 1355.6 ± 189.5 vs. PLA 
1332.3 ± 173.3 s, P > 0.05) during the second 5000 m split. 
Magnitude based inferences indicated a ‘very likely benefi-
cial’ effect of BRJ during the first 5000 m, and an ‘unclear’ 
effect of BRJ during the second 5000 m of the 10,000 m 
TT.
Discussion
The main finding of the present investigation was that acute 
supplementation with BRJ significantly enhanced 1500 m 
treadmill TT performance, but not 10,000  m treadmill 
TT performance. This suggests that BRJ supplementation 
might improve performance in trained males conducting 
shorter distance TTs which allow for a high work rate, but 
not necessarily during longer distance TTs where a lower 
work rate is mandated.
Effects of BRJ on plasma  [NO2−] and blood pressure
In agreement with the findings of a number of earlier 
investigations (e.g. Bailey et  al. 2009, 2010; Vanhatalo 
et  al. 2010; Lansley et  al. 2011; Cermak et  al. 2012a; 
Wylie et al. 2013; Muggeridge et al. 2014; Shannon et al. 
2016b; McMahon et al. 2016), BRJ supplementation sig-
nificantly elevated pre-exercise plasma  [NO2−], which is a 
highly sensitive marker of NO bioavailability (Lundberg 
et al. 2008). Interestingly, despite close replication of diet 
Table 1  Mean (±SD) cardiopulmonary variables and perceived exer-
tion during the 1500 and 10,000 m TTs with BRJ and PLA supple-
mentation
1500 m 10,000 m
PLA BRJ PLA BRJ
HR (b·min− 1) 187 ± 8 187 ± 4 180 ± 12 182 ± 13
RPE 19 ± 1 19 ± 1 19 ± 1 19 ± 1
V̇O
2
(ml·kg−1·min−1)
53.9 ± 6.9 53.4 ± 6.8 48.6 ± 6.3 49.0 ± 6.0
V̇CO
2
(ml·kg−1·min−1)
61.8 ± 10.5 61.1 ± 11.2 50.2 ± 6.5 52.7 ± 8.4
RER 1.15 ± 0.10 1.15 ± 0.10 1.03 ± 0.10 1.08 ± 0.10
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and exercise for 24  h preceding each trial, administra-
tion of identical batch checked supplements, and a con-
sistent time-frame for post-supplement blood sampling, 
there was some variation in pre-exercise plasma  [NO2−] 
between the two BRJ conditions, and between the two 
PLA conditions. Given pre-exercise plasma  [NO2−] was 
Fig. 2  The transient changes in pulmonary gas-exchange data with 
BRJ (closed circles/triangles) and PLA (open circles/triangles) 
throughout the 1500 m (a–c) and 10,000 m (d–f) TTs. Data for the 
1500  m TT represents average values over 200  m intervals up to 
1400 m, and during the final 100 m. Data for the 10,000 m TT repre-
sents average values over 1000 m intervals
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~5–6-fold greater in both BRJ conditions compared to 
PLA, and remained elevated above PLA post-exercise, it 
is likely that the difference in the performance response to 
BRJ between 1500 and 10,000 m exercise test protocols 
is not attributable to insufficient availability of  NO2− as a 
‘substrate’ for NO generation in the 10,000 m BRJ trial. 
Plasma  [NO2−] did not significantly decrease post-exer-
cise in the BRJ 10,000 m condition, yet declined signifi-
cantly in the BRJ 1500 m condition. This suggests that it 
is differences in the ‘use’ rather than the availability of 
 NO2− that is important. This might be related to greater 
acidosis and hypoxia, and thus  NO2− reduction (Modin 
et al. 2001; Cosby et al. 2003; Castello et al. 2006), in the 
1500 vs. 10,000  m conditions, as a consequence of the 
relatively greater work rate adopted (~86 vs. 78% V̇O
2max
; 
~6.5 vs. 4.5 mM blood [Lactate]).
The increase in plasma  [NO2−] with BRJ did not 
translate into a significant reduction in BP, as evident by 
similar MAP values between conditions. Previous inves-
tigations indicate that the magnitude of the decline in BP 
typically observed with  NO3− supplementation is related 
to the initial BP of the subject (Ashworth et  al. 2015). 
Thus, it is possible that the relatively low BP in these 
subjects minimized the effects of  NO3− supplementation 
on this parameter.
Fig. 3  Individual performance times and running speed during the 
1500 and 10,000  m TT tests. Performance in the 1500  m TT was 
significantly faster (asterisk) in BRJ (filled circles) compared with 
PLA (open circles) (a) (P < 0.05). There was no significant dif-
ference in 10,000  m TT performance between BRJ (filled trian-
gles) and PLA (open triangles) (c). Running speed did not signifi-
cantly differ between BRJ (closed circles/triangles) and PLA (open 
circles/triangles) in the 1500 m (b) and 10,000 m (d) TT tests
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Effects of BRJ on 1500 m TT performance
In the cohort of trained men recruited for this study, it was 
hypothesized that BRJ would enhance 1500  m TT per-
formance. In agreement with previous literature and our 
experimental hypothesis, BRJ supplementation signifi-
cantly enhanced 1500 m running performance, with a mean 
improvement of 1.9%—an effect deemed ‘very likely ben-
eficial’ via magnitude based inferential statistics. These 
data are comparable to previous studies which have dem-
onstrated that the ingestion of dietary  NO3− significantly 
enhances short duration (<30  min) TTE and/or TT per-
formance in untrained and moderately-trained individuals 
(V̇O
2max
 < ~60 ml kg−1 min−1) (Bailey et al. 2009, 2010; 
Vanhatalo et  al. 2010; Lansley et  al. 2011; Cermak et  al. 
2012a, b; Porcelli et  al. 2014). In contrast, limited effects 
of  NO3− supplementation have been reported for similar 
duration exercise tests in individuals with a greater train-
ing status (i.e. well-trained and elite athletes) (V̇O
2max
 >70 
ml·kg−1·min−1) (Peacock et  al. 2012; Bescós et  al. 2012; 
Christensen et al. 2013; Porcelli et al. 2014; Sandbakk et al. 
2015). These highly trained athletes manifest a host of dif-
ferent characteristics likely to diminish their responsive-
ness to  NO3− supplementation (for review, see Jones 2014), 
including elevated endogenous  NO3− and  NO2− reserves 
(Vassalle et al. 2003).
Regular splits were obtained throughout TTs, which 
allowed us to compare the pacing strategy between BRJ 
and PLA conditions, and identify the points at which BRJ 
might have enhanced running speed. Although there were 
no significant differences in running speed at any of the 
splits, subjects tended to run faster during the first 1000 m 
of the 1500 m TT in BRJ compared with PLA, such that 
the majority of time ‘gained’ in BRJ occurred during this 
period. Subjects achieved similar running speeds between 
1000 and 1400  m, although this represented a greater 
percentage of average pace in PLA which could not be 
maintained. Consequently, subjects were typically una-
ble to employ a sprint finish in PLA, unlike in BRJ. The 
apparent benefits of BRJ during the first and last phases 
of the 1500  m TT could be of tactical advantage during 
competition.
A range of mechanisms might explain the ergogenic 
effect of  NO3− supplementation on 1500  m TT perfor-
mance observed here. Multiple previous studies have 
reported a reduction in the  O2 cost of exercise with 
 NO3− supplementation (Larsen et  al. 2007; Bailey et  al. 
2009; Lansley et al. 2011; Cermak et al. 2012a; Wylie et al. 
2013; Pawlak-Chaouch et  al. 2016), consequent to either 
an improvement in the efficiency of mitochondrial respira-
tion (Larsen et  al. 2011) and/or muscle contraction (Bai-
ley et  al. 2010). However, this mechanism cannot explain 
the improvement in performance observed in this study, as 
BRJ supplementation did not reduce  O2 consumption dur-
ing exercise. Instead, the ergogenic effect of BRJ may be 
better explained by other physiological changes. Interest-
ingly, recent murine model studies have identified effects 
of  NO3− which appear to be selective to type II muscle 
(for review, see Jones et al. 2016), and may be of mecha-
nistic relevance in the present study given the likely high 
recruitment of type II fibers during the 1500 m TT (Essén 
1978; Sale 1987).  NO3− supplementation was reported to 
augment blood flow and thus  O2 delivery to type II mus-
cle in exercising rats (Ferguson et  al. 2013, 2015). It was 
suggested that these local blood flow changes might be 
beneficial by increasing the microvascular partial pres-
sure of  O2 (PO2), and concomitantly decreasing muscle 
metabolic perturbations (e.g. PCr degradation, ADP and Pi 
accumulation)—effects previously demonstrated to extend 
TTE with  NO3− supplementation in humans (Bailey et al. 
2010; Vanhatalo et al. 2011). The enhanced 1500 m exer-
cise performance subsequent to BRJ in the present study 
may thus, at least partly, be underpinned by changes to 
type II muscle blood flow and  O2 delivery. Additionally, 
Hernandez et al. (2012) observed an increased expression, 
and therefore content, of the  Ca2+ handling protein calse-
questrin 1 and the dihydropyridine receptor. These effects, 
which were reported in predominantly type II muscle, were 
accompanied by an increased muscle force production. 
Subsequent studies have confirmed the beneficial effect 
of  NO3− on force production in humans (Haider and Fol-
land 2014; Coggan et al. 2015). It is therefore possible that 
elevated type II muscle  Ca2+ handling and muscle contrac-
tile function may have further contributed to the improved 
1500  m performance observed in the present investiga-
tion. Furthermore, several recent studies have observed 
improvements in physiological functioning and exercise 
performance in situations where type II muscle recruitment 
is likely to be high (Breese et al. 2013; Bailey et al. 2015; 
Coggan et al. 2015), which further supports the findings of 
this investigation.
Effects of BRJ on 10,000 m TT performance
There was no significant difference in 10,000  m TT per-
formance between BRJ and PLA in this study. Magnitude 
based inferences also indicated an ‘unclear’ practical effect 
of BRJ on 10,000  m TT performance. Nevertheless, four 
subjects exceeded the SWC in performance following BRJ 
in the present study, supporting the notion of a responder 
vs. non-responder phenomenon (Wilkerson et al. 2012).
Interestingly, subjects appeared to adopt disparate 
pacing strategies in BRJ and PLA conditions. In BRJ, 
subjects ran the first 5000 m significantly faster, yet the 
pace gradually declined throughout the TT before a final 
sprint finish. Conversely, in PLA subjects adopted a more 
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even paced strategy prior to a similar paced sprint fin-
ish. While it is important to acknowledge that overall 
10,000  m performance was no different between condi-
tions, the faster first 5000  m with BRJ might offer tac-
tical advantages in competition. In contrast, Wilkerson 
et al. (2012) observed no difference in power output dur-
ing the earlier stages of a 50 mile (total exercise dura-
tion: >2 h) cycle ergometry TT, yet the final 10 miles was 
faster with  NO3− supplementation. Together, these find-
ings might suggest a potential application of BRJ during 
higher work rate periods within a longer duration event, 
perhaps specifically those which require greater type II 
muscle recruitment or markedly decrease the muscle pH 
and PO2 and hence, augment  NO2− reduction into NO 
(Modin et  al. 2001; Cosby et  al. 2003; Castello et  al. 
2006). This might include facilitating a fast start or finish 
during competition, or responding to a surge by another 
competitor. Investigations into the performance effects of 
 NO3− supplementation during ‘real world’ competition 
would provide interesting insight.
The effects of  NO3− supplementation are likely deter-
mined by an interaction between multiple variables, 
rather than individual factors, and hence the results of 
this study cannot easily be generalised to other popu-
lations or experimental conditions. Aerobic fitness 
strongly moderates the effects of  NO3− supplementation 
(Porcelli et  al. 2014), such that the beneficial effects of 
 NO3− supplementation on 1500 m TT performance might 
not be applicable to individuals with a higher training 
status (Boorsma et al. 2014). Likewise, it is possible that 
untrained individuals may derive a beneficial effect of 
 NO3− supplementation during longer duration (>30 min) 
lower work rate exercise tests, which remains to be 
explored. Additionally, there is some evidence to suggest 
that chronic dosing might elicit more robust physiologi-
cal and performance changes (Vanhatalo et  al. 2010). 
Therefore, it cannot be ruled out that  NO3− supplemen-
tation may be beneficial for longer duration lower work 
rate exercise tests or in trained individuals when more 
protracted supplementation strategies are applied. Future 
investigations exploring the potential interaction between 
these and other variables are warranted, to help eluci-
date the precise conditions where  NO3− supplementation 
might be beneficial.
In conclusion, the results of the present study suggest 
that acute BRJ supplementation increases plasma  [NO2−], 
and enhances 1500 m treadmill TT performance in trained 
men. In contrast, BRJ supplementation did not significantly 
enhance 10,000 m TT performance. These findings provide 
important insight into the specific conditions where BRJ 
supplementation may be ergogenic, and evidence that the 
ergogenic effect of  NO3− supplementation is moderated by 
the duration and requisite work rate of a TT.
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